Class information for:
Level 1: OMALIZUMAB//ANTI IGE//ANTI IMMUNOGLOBULIN E

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
10454 1062 36.4 77%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
315 3       ALLERGY//MAST CELLS//BRADYKININ 39886
775 2             MAST CELLS//MASTOCYTOSIS//CHYMASE 12239
10454 1                   OMALIZUMAB//ANTI IGE//ANTI IMMUNOGLOBULIN E 1062

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OMALIZUMAB authKW 5227242 28% 61% 300
2 ANTI IGE authKW 1819197 11% 55% 115
3 ANTI IMMUNOGLOBULIN E authKW 551268 2% 91% 21
4 IGE authKW 292874 19% 5% 204
5 FC EPSILON RI authKW 243590 5% 15% 56
6 ANTI IGE ANTIBODY authKW 193263 1% 61% 11
7 XOLAIR authKW 179687 1% 63% 10
8 ALLERGIC ASTHMA authKW 154645 5% 9% 58
9 RHUMAB E25 authKW 143756 0% 100% 5
10 HIGH AFFINITY IGE RECEPTOR authKW 137426 1% 34% 14

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Allergy 70983 38% 1% 405
2 Immunology 11867 50% 0% 536
3 Respiratory System 1651 11% 0% 114
4 Biochemistry & Molecular Biology 186 15% 0% 163
5 Medicine, Research & Experimental 134 5% 0% 57
6 Medicine, General & Internal 65 5% 0% 57
7 Pharmacology & Pharmacy 64 7% 0% 77
8 Dermatology 61 2% 0% 25
9 Critical Care Medicine 57 2% 0% 19
10 Biochemical Research Methods 35 3% 0% 31

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MOL BIOLBUNKYO KU 64689 0% 75% 3
2 ALLERGY BUNKYO KU 57502 0% 100% 2
3 ARBEITSGRP PNEUMOL ALLERGOL MUKOVISZIDOSE 57502 0% 100% 2
4 RCMB 41815 0% 36% 4
5 PEDIAT P DIS ALLERGY 38334 0% 67% 2
6 19 GREEN BELT DR 28751 0% 100% 1
7 ALLERG MECHANISMS 28751 0% 100% 1
8 ALLERGY IMMUNOLLEBONHEUR HOSP 28751 0% 100% 1
9 ALLERGY MED CLIN 28751 0% 100% 1
10 ALLERGY MOL BIOL 28751 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY 16958 5% 1% 50
2 ALLERGY 11986 5% 1% 51
3 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 10735 6% 1% 63
4 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 9761 3% 1% 30
5 ALLERGY AND ASTHMA PROCEEDINGS 8781 2% 1% 22
6 JOURNAL OF ASTHMA 7473 3% 1% 28
7 ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 5307 2% 1% 26
8 MOLECULAR IMMUNOLOGY 4679 3% 0% 34
9 CURRENT ALLERGY AND ASTHMA REPORTS 4227 1% 1% 12
10 CLINICAL AND EXPERIMENTAL ALLERGY 3809 2% 1% 26

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 OMALIZUMAB 5227242 28% 61% 300 Search OMALIZUMAB Search OMALIZUMAB
2 ANTI IGE 1819197 11% 55% 115 Search ANTI+IGE Search ANTI+IGE
3 ANTI IMMUNOGLOBULIN E 551268 2% 91% 21 Search ANTI+IMMUNOGLOBULIN+E Search ANTI+IMMUNOGLOBULIN+E
4 IGE 292874 19% 5% 204 Search IGE Search IGE
5 FC EPSILON RI 243590 5% 15% 56 Search FC+EPSILON+RI Search FC+EPSILON+RI
6 ANTI IGE ANTIBODY 193263 1% 61% 11 Search ANTI+IGE+ANTIBODY Search ANTI+IGE+ANTIBODY
7 XOLAIR 179687 1% 63% 10 Search XOLAIR Search XOLAIR
8 ALLERGIC ASTHMA 154645 5% 9% 58 Search ALLERGIC+ASTHMA Search ALLERGIC+ASTHMA
9 RHUMAB E25 143756 0% 100% 5 Search RHUMAB+E25 Search RHUMAB+E25
10 HIGH AFFINITY IGE RECEPTOR 137426 1% 34% 14 Search HIGH+AFFINITY+IGE+RECEPTOR Search HIGH+AFFINITY+IGE+RECEPTOR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 LAI, TW , WANG, SB , XU, ZW , ZHANG, C , ZHAO, Y , HU, Y , CAO, C , YING, SM , CHEN, ZH , LI, W , ET AL (2015) LONG-TERM EFFICACY AND SAFETY OF OMALIZUMAB IN PATIENTS WITH PERSISTENT UNCONTROLLED ALLERGIC ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.SCIENTIFIC REPORTS. VOL. 5. ISSUE . P. - 53 85% 7
2 LUU, M , BARDOU, M , BONNIAUD, P , GOIRAND, F , (2016) PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL EFFICACY OF OMALIZUMAB FOR THE TREATMENT OF ASTHMA.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 12. ISSUE 12. P. 1503 -1511 55 82% 0
3 NORMANSELL, R , WALKER, S , MILAN, SJ , WALTERS, EH , NAIR, P , (2014) OMALIZUMAB FOR ASTHMA IN ADULTS AND CHILDREN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - 55 71% 20
4 HUMBERT, M , BUSSE, W , HANANIA, NA , LOWE, PJ , CANVIN, J , ERPENBECK, VJ , HOLGATE, S , (2014) OMALIZUMAB IN ASTHMA: AN UPDATE ON RECENT DEVELOPMENTS.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. VOL. 2. ISSUE 5. P. 525 -+ 51 69% 30
5 PELAIA, G , VATRELLA, A , BUSCETI, MT , GALLELLI, L , TERRACCIANO, R , MASELLI, R , (2015) ANTI-IGE THERAPY WITH OMALIZUMAB FOR SEVERE ASTHMA: CURRENT CONCEPTS AND POTENTIAL DEVELOPMENTS.CURRENT DRUG TARGETS. VOL. 16. ISSUE 2. P. 171 -178 56 74% 1
6 LICARI, A , MARSEGLIA, G , CASTAGNOLI, R , MARSEGLIA, A , CIPRANDI, G , (2015) THE DISCOVERY AND DEVELOPMENT OF OMALIZUMAB FOR THE TREATMENT OF ASTHMA.EXPERT OPINION ON DRUG DISCOVERY. VOL. 10. ISSUE 9. P. 1033 -1042 45 87% 1
7 ABRAHAM, I , ALHOSSAN, A , LEE, CS , KUTBI, H , MACDONALD, K , (2016) 'REAL-LIFE' EFFECTIVENESS STUDIES OF OMALIZUMAB IN ADULT PATIENTS WITH SEVERE ALLERGIC ASTHMA: SYSTEMATIC REVIEW.ALLERGY. VOL. 71. ISSUE 5. P. 593 -610 35 78% 6
8 MCKEAGE, K , (2013) OMALIZUMAB: A REVIEW OF ITS USE IN PATIENTS WITH SEVERE PERSISTENT ALLERGIC ASTHMA.DRUGS. VOL. 73. ISSUE 11. P. 1197-1212 46 82% 14
9 KUHL, K , HANANIA, NA , (2012) TARGETING IGE IN ASTHMA.CURRENT OPINION IN PULMONARY MEDICINE. VOL. 18. ISSUE 1. P. 1-5 38 90% 23
10 BUSSE, W , BUHL, R , VIDAURRE, CF , BLOGG, M , ZHU, J , EISNER, MD , CANVIN, J , (2012) OMALIZUMAB AND THE RISK OF MALIGNANCY: RESULTS FROM A POOLED ANALYSIS.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. VOL. 129. ISSUE 4. P. 983-U482 39 80% 35

Classes with closest relation at Level 1


Rank Class id link
1 7024 SEVERE ASTHMA//INDUCED SPUTUM//SPUTUM CELL COUNTS
2 7462 CD23//SOLUBLE CD23//FC EPSILON RII
3 27946 DS 4574//ALLERGY TYPE I IV//ANTIBODY MEDIATED ARTHRITIS
4 3910 RBL 2H3 CELLS//MAST CELLS//FC EPSILON RI
5 8772 BASOPHILS//CD203C//CD63
6 34415 SUPLATAST TOSILATE//CX 659S//TH2 TYPE REACTION
7 11520 ATOPIC DERMATITIS//ATOPY PATCH TEST//NC NGA MICE
8 22983 STEROID DEPENDENT ASTHMA//STEROID RESISTANT ASTHMA//ACUTE AIRWAY REACTION
9 3827 CHRONIC URTICARIA//URTICARIA//CHRONIC IDIOPATHIC URTICARIA
10 31640 ANGIOTENSIN II VACCINE//EA4222//KINOID

Go to start page